European Commission
Spain's Sequentia Biotech Raises €10M in Series A Funding Round
Sequentia said the funding will accelerate the path to market for its MICK platform for clinical microbiome data analysis and interpretation.
Illumina Wins Jurisdictional Appeal in Europe Over Grail Deal, Dodges €432M Fine
In its decision, the European Court of Justice also ordered the European Commission to pay legal costs incurred by Illumina and Grail.
Illumina to Spin off Grail by Issuing Shares to Investors, Will Keep 14.5 Percent
Illumina shareholders will receive one share of Grail for every six shares of Illumina stock, with cash issued in lieu of fractional shares.
European Commission Approves Illumina's Plan for Divesting Grail
Whether Illumina will sell Grail to another firm or pursue a capital markets transaction such as an initial public offering is yet to be determined.
Illumina Shares Rise 5 Percent on Favorable Legal Opinion Submitted to European Court
The opinion is nonbinding, but if the European court accepts it, Illumina could escape fines of nearly half a billion dollars, among other cash outlays.
Oct 12, 2023
European Commission Orders Illumina to Divest Grail
Dec 16, 2022
Nov 17, 2022
Sep 6, 2022
EU to Disallow Illumina's Grail Purchase
Aug 12, 2022
Sep 29, 2021